Prescription Drug Monitoring Act of 2024
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Prescription Drug Monitoring Act of 2024 (S.5228) was a Senate bill introduced in the 118th Congress aimed at addressing issues related to prescription drug monitoring. The bill was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions but did not advance further and ultimately failed or expired. Specific details about the bill's provisions, objectives, or mechanisms are not available in the provided source data.
S.5228 sought to legislate on prescription drug monitoring but did not progress beyond committee referral and expired without enactment.
- The bill was introduced in the Senate during the 118th Congress and referred to the Committee on Health, Education, Labor, and Pensions.
- No official summary or full text is available, limiting detailed analysis of the bill's content or provisions.
- The bill's status is recorded as failed or expired, indicating it did not become law.
['Potential beneficiaries could have included healthcare providers, patients, and regulatory agencies involved in prescription drug monitoring, though specifics are not provided.']
['Lack of available text and summary restricts assessment of implementation challenges, costs, or oversight mechanisms.', 'Without details, it is unclear how authority or enforcement would have been structured.']
The bill was introduced and referred to a relevant Senate committee but did not advance further, reflecting either limited legislative support or prioritization within the 118th Congress. No additional context or debate records are provided.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have influenced prescription drug monitoring practices, potentially affecting healthcare data sharing, patient privacy, and regulatory oversight, but specifics cannot be determined from available data.']
The absence of an official summary and full bill text significantly limits transparency and public understanding of the bill's intent, provisions, and potential impacts. This lack of information hinders effective oversight and informed public discourse.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.